TEN
TEN
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
0
$0
Total Volume
$0
4 transactions
Net Activity
+$0
Net buying
Sentiment Rating
Neutral / BalancedCEO Conviction Index
No Recent Signal
Key Drivers
- •Balanced trading volume with net neutral buying and selling activity.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
TEN has an insider buy conviction of 50%, compared to the Unknown sector buy average of 50%. TEN ranks #135 in insider activity out of 323 tracked companies in its industry.
Multiple Insiders
S - Sale Insiders
$0 total
Over the last 90 days, corporate insiders at TEN (TEN) engaged in a total of 4 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 0 were sales. The total volume of insider trading reached $0.
The net insider activity for TEN shows a net buying bias of $0. This activity represents a 50% buy ratio, suggesting that insiders are currently neutral on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (S - Sale Insiders), who traded 14.7K shares valued at $0 on Sep 18, 2026.
Quick Actions
Related News & Analyst Reports
Read original insights and educational research covering TEN and the Unknown sector.
The Biotech Executive Playbook: Tracking Clinical Phase SEC Filings
An empirical study on how clinical-stage biotech executives execute Form 4 open-market purchases ahead of trial data releases, outlining the regulatory gaps and alpha potential of clinical insider tracking.
The Quant Guide: Backtesting SEC Form 4 Cluster Buys for Alpha
A rigorous quantitative backtest of SEC Form 4 cluster buying activity, demonstrating how to isolate signal from noise and build portfolios that consistently outperform benchmarks.
The Impact of Interest Rates on Insider Behavior: A Macro Analysis
When the Fed tightens, equity valuations fall, but insider purchase activity does not always follow the same pattern. This report examines three rate-hike cycles to show how rising rates affect the frequency and conviction of C-suite stock buys.
Sequoia Capital and the Mechanics of Venture Lock-Up Extensions
Sequoia Capital pioneered the use of voluntary lock-up extensions to signal portfolio company confidence. This report analyzes the market-price impact of Sequoia extension announcements and whether they have historically justified the delay.
Deciphering Option Exercises (Code M) vs. Open Market Purchases (Code P)
Transaction code M (option exercise) is often mistaken for bullish conviction, but it usually means nothing. Learn why Code P open-market purchases are the only Form 4 entries that signal genuine insider belief.
How CFOs Trade vs. CEOs: A Data-Driven Analysis of Who Reads Markets Better
Decades of academic research consistently shows that CFOs are more accurate insiders than CEOs when it comes to stock purchases. This analysis explains why — covering the informational advantages of the CFO role, how their trading patterns differ from CEOs, and what specific CFO buying patterns investors should watch for.
FAQs About TEN Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for TEN.